To capitalize on the vast potential of patient genetic information to aid in assuring drug safety, a substantial effort is needed in\r\nboth the training of healthcare professionals and the operational enablement of clinical environments. Our research aims to satisfy\r\nthese needs through the development of a drug safety assurance information system (GeneScription) based on clinical genotyping\r\nthat utilizes patient-specific genetic information to predict and prevent adverse drug responses. In this paper, we present the\r\nmotivations for this work, the algorithms at the heart of GeneScription, and a discussion of our system and its uses. We also\r\ndescribe our efforts to validate GeneScription through its evaluation by practicing pharmacists and pharmacy professors and its\r\nrepeated use in training pharmacists. The positive assessment of the GeneScription software tool by these domain experts provides\r\nstrong validation of the importance, accuracy, and effectiveness of GeneScription.
Loading....